1. Home
  2. IMTX vs CPAC Comparison

IMTX vs CPAC Comparison

Compare IMTX & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMTX
  • CPAC
  • Stock Information
  • Founded
  • IMTX N/A
  • CPAC 1949
  • Country
  • IMTX Germany
  • CPAC Peru
  • Employees
  • IMTX N/A
  • CPAC N/A
  • Industry
  • IMTX Biotechnology: Biological Products (No Diagnostic Substances)
  • CPAC Building Materials
  • Sector
  • IMTX Health Care
  • CPAC Industrials
  • Exchange
  • IMTX Nasdaq
  • CPAC Nasdaq
  • Market Cap
  • IMTX 653.9M
  • CPAC 544.2M
  • IPO Year
  • IMTX N/A
  • CPAC 2012
  • Fundamental
  • Price
  • IMTX $6.33
  • CPAC $6.15
  • Analyst Decision
  • IMTX Strong Buy
  • CPAC Sell
  • Analyst Count
  • IMTX 4
  • CPAC 2
  • Target Price
  • IMTX $14.67
  • CPAC $6.20
  • AVG Volume (30 Days)
  • IMTX 537.7K
  • CPAC 4.0K
  • Earning Date
  • IMTX 08-13-2025
  • CPAC 07-21-2025
  • Dividend Yield
  • IMTX N/A
  • CPAC 8.15%
  • EPS Growth
  • IMTX N/A
  • CPAC 26.68
  • EPS
  • IMTX N/A
  • CPAC 0.14
  • Revenue
  • IMTX $152,823,253.00
  • CPAC $572,828,408.00
  • Revenue This Year
  • IMTX N/A
  • CPAC N/A
  • Revenue Next Year
  • IMTX $1.92
  • CPAC N/A
  • P/E Ratio
  • IMTX N/A
  • CPAC $8.67
  • Revenue Growth
  • IMTX 83.61
  • CPAC 3.37
  • 52 Week Low
  • IMTX $3.30
  • CPAC $5.10
  • 52 Week High
  • IMTX $13.09
  • CPAC $6.65
  • Technical
  • Relative Strength Index (RSI)
  • IMTX 52.73
  • CPAC 47.97
  • Support Level
  • IMTX $5.56
  • CPAC $6.01
  • Resistance Level
  • IMTX $6.50
  • CPAC $6.37
  • Average True Range (ATR)
  • IMTX 0.35
  • CPAC 0.14
  • MACD
  • IMTX -0.07
  • CPAC -0.03
  • Stochastic Oscillator
  • IMTX 62.10
  • CPAC 35.64

About IMTX Immatics N.V.

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: